Independence Well- being and Choice 2005, Our health, our care, our say 2006, Strong and Prosperous 2006
|
|
- Allison Rich
- 5 years ago
- Views:
Transcription
1
2 Medicines Op+misa+on Outcome focused approach to safe and effec+ve use of medicines that takes into account the pa+ent s values, percep+on and experience of taking their medicines Important Outcomes for adults Improved quality of life Making a posi8ve contribu8on Improved health and emo8onal wellbeing Personal Dignity Control and choice Economic wellbeing Freedom from discrimina8on Independence Well- being and Choice 2005, Our health, our care, our say 2006, Strong and Prosperous Communi@es 2006 h3p:// pharmacy- pdfs/helping- pa8ents- make- the- most- of- their- medicines.pdf
3 Older people and medicines Op8mising medicines use can have a high impact on pa8ent experience, health outcomes and costs Naylor S et al. Kings Fund Transforming our health care system: Ten priori8es for commissioners h3p://experienceinvest.com/tag/healthcare- property/
4 Frail Older People 10% of over 65s and 25-50% over 85s 1 Take more medicines (mostly repeats) Higher risks of adverse drug events (ADEs) Frequent hospital admissions and longer stays Higher users of primary care and social care resources Many will manage be@er at home in crisis with the right support to meet their needs (BGS Fit for Frailty 2014) Young et al. Lancet
5 Frailty Age- associated decline in physiologic reserve and func+on across mul8- organ systems leading to increased vulnerability for adverse health outcomes (Fried et al 2001) A dis8nct health state where a minor event can trigger major changes in health from which the pa8ent may fail to return to their previous level of health (Bri8sh Geriatric Society) Co- morbidi+es Acute illness Adverse outcomes Social vulnerability Ageing Progressive condi8on, with episodic deteriora8ons
6 Poor resilience to stressors
7 Frailty markers Frailty Phenotype ( 3) Weakness Slowness Low level of physical ac8vity Self- reported exhaus8on Uninten8onal weight loss (Fried et al 2001) Acute Illness oten present as frailty syndromes Falls Immobility Delirium Incon8nence Suscep+bility to ADEs
8 Focusing community services on those with frailty rather than on those at highest risk of hospital admission might improve quality of pa8ent care and reduce hospital bed usage BGS Fit for Frailty 2
9 Premises underpinning frailty services 1. Interven8ons across health and social care aimed at improving physical, mental and social func8oning to avoid adverse events like hospitalisa8on vs strictly disease- orientated biomedical approach 2. Individualised treatment and interven8ons 3. Sustained support over a long 8me that con8nues even through intervening crises and adverse events. 4. Interven8on plan that enables par8cipa8on of the older person. 5. Engagement with the family and/ or carers BGS Fit for Frailty
10 Evidence: Pharmacist led interven+ons reducing hospital admissions No evidence of impact of medica8on reviews on hospital bed use (Philp I et al IJIC 2013) Systema8c reviews and Meta analysis (Thomas R Age and Ageing 2014) Interven8ons led by hospital pharmacists reduce unplanned hospital admissions in older pa8ents with heart failure (3RCTs) Interven8ons led by hospital or community pharmacists for the general older popula8on do not reduce unplanned admissions (16 trials) Many interven8ons that might be expected to avoid admissions, including home based medica8on reviews do not (Kings Fund 2010) Bo3om line No robust evidence that pharmacist led interven8ons reduce hospital admissions in older people
11 Adverse Drug Event (ADE) or Drug Related Problem Adverse drug reac8ons (ADRs) i.e. unwanted or harmful effect of medica8on failure by the pa8ent to take the medicine as intended, Medica8on errors e.g. prescribing, dispensing or administra8on errors Inappropriate or over treatment being prescribed Failure to prescribe an indicated treatment Medica8on discrepancies i.e. unexplained differences in documented medica8on regimens, par8cularly at transfer of care
12 General points ADEs can cause serious harm to pa8ents and lead to hospitalisa8on or death Terminology used in literature vary : ADRs are one cause of ADEs Rates of drug related hospital admissions vary widely 0.1% to 45% Clinical coding captures some ADRs but, generally underes8mate. Coding will not capture ADEs Not all ADEs or ADRs are preventable Highest risks: elderly pa8ents with mul8ple co- morbidi8es and receiving mul8ple medicines Medicines Related problems on Admission to Hospital - The Evidence h3p:// Medicines_related_problems_on_admission_the_evidence_Apr14Vs1_JW.pdf
13 WeMeRec. Medicines- related admissions.2015 At least 5% of hospital admissions are medicines related 80% are due to ADR Root causes of MRAs are complex Successful interven8ons to reduce the scale of the problem will need to involve primary and secondary care, as well as pa8ents.
14 Medicines- related admissions (WeMeRec 2015) Pa+ent- related risk factors Impaired cogni8on Four or more diseases in pa8ent s medical history Dependent living situa8on Impaired renal func8on before hospital admission Non- adherence to medica8on regimen Age > 65 years (more likely to experience an ADR)
15 Medicines- related admissions (WeMeRec 2015) Medica+on- related risk factors General Polypharmacy ( 5 medicines at the 8me of admission)* New medicine started within the last 7 days Complex medica8on regimens at hospital admission (Predic8ve of re- hospitalisa8ons for ADRs) Specific drugs An8coagulants An8platelet agents Diure8cs NSAIDs ACE inhibitors
16 Causes of PDRAs (Qual Saf Health Care 2008) Problems at mul8ple stages in the medica8on use process Prescribing, dispensing, administra8on, monitoring, help seeking Main causes of problems irrespec8ve of associa8on Communica8on failures (between pa8ents and healthcare professionals and different groups of healthcare professionals) Knowledge gaps (about drugs and pa8ents medical and medica8on histories). Conclusions The causes of PDRAs are mul8faceted and complex. Technical solu+ons to PDRAs will need to take account of this complexity and are unlikely to be sufficient on their own. Interven+ons targe+ng the human causes of PDRAs are also necessary for example, improving methods of communica+on.
17 Causes of PDRA (Howard et al BJCP 2006) Systema8c review of 13 papers Range %( mean 3.7) PDRAs Associated with prescribing problems (30.6%) adherence problems (33.3%) monitoring problems (22.2%) 50% of PDRAs involved four groups of drugs; an8- platelets (16%) diure8cs (16%) NSAIDs (11%) an8- coagulants (8%).
18 PDRAs and readmissions (Davies EC et al BJCP 2010) Small UK hospital study (n91) Approximately 20% of pa8ents readmi3ed to hospital within a year of discharge were re- admi3ed due to a suspected ADR 57% definitely or possibly avoidable. In 30% (n=11/37) of pa8ents readmi3ed within 28 days of discharge the causa8ve drug had been ini8ated in during the index admission.
19 Managing ADE in the community is Everybody s business: A mul+disciplinary approach is needed Suppor+ng self- medica+on Administering medicines Adverse drug reac+ons (ADRs) Monitoring medicine effects Pa8ent outcomes Non Adherence Polypharmacy Medicines reconcilia+on and Transfer of Info (De) Prescribing & Medica+on reviews (health only) 19
20 PDRAs in the real world.
21 Pa+ent centred pharmaceu+cal care to reduce avoidable drug related readmission Blagburn J et al EJHP 2015 Socially isolated pa8ents and/or on high- risk medicines Older people s medical ward x 1 year plus control Readmission rates 12mths before and 12 mths of interven8on period (retrospec8vely) Readmission rate was significantly lower on the interven8on ward (69/418) vs control ward (107/490); 17% vs 22%, p<0.05 Person- centred risk assessment and risk management for older people and their medica8ons in hospital may reduce the likelihood of 30- day readmission by 40%. Using a monitored dosage system for medicines at home may be a significant risk factor for hospital readmission.
22 Hypothesis and Interven+on Prac88oner behaviors and/or pa8ent- specific factors (medical condi8on & adherence) may be more accurate predictors of hospital readmission risk than the individual s epidemiological grouping Person- centred pharmaceu8cal care during and ater a hospital admission, that meets each individual s need for informa8on, risk management or support to take their medicines may reduce readmissions caused by non- adherence or troublesome side effects. Consulta+on Clinical pharmacists and pa8ents encounters moved from giving informa8on to pa8ent led conversa8ons, with shared treatment decisions and joint solu8ons to problems iden8fied Interven+ons Medicine reconcilia8on, shared decision making, mo8va8onal interview techniques, real- 8me discharge communica8on, assessing a person s usual support network for suitability, providing person- centred informa8on
23 Pharmaceu8cal Care bundle
24 Pharmacy- led integrated medicines management (IMM) project NWLH NHS Nina Barne3 et al Managing Preventable Medicines Related Readmission (PMRR) Parallel cohort study (836 pa8ents) Used PREVENT tool to iden8fy high risk pa8ents- 3 domains medicine- specific, clinical and social risks Causes of preventable readmission are mul8factorial Working within MDT to iden8fy/minimise the PMRR is cri8cal. The most frequent reasons for referral to the service Adherence issues (69%) Compliance support requests (29%) Pa8ents with cogni8ve impairment requiring help (29%) Pa8ents taking high risk medicines without appropriate monitoring or review in place (20%). Some pa8ents were referred for more than one reason.
25 Interven8on and results Referral to the IMM pharmacist team for medicines reconcilia8on & review, discharge planning and post discharge follow up Innova8ve coaching approach to consulta8on Collabora8on across MDT health & social care teams Readmissions within 30 days discharge 16% (IMM service site) vs 18% (standard service site) PMRR 0.3% (IMM site) vs 4.4% (standard service site) sta8s8cally significant reduc8on (P=0.002). Saving: 3 for every 1 spent on an IMM pharmacist Future work pa8ent experience, coding to iden8fy high risk pa8ents on admission, linking with primary care to iden+fy and manage pa+ents in the community
26 Integrated Medicines op+misa+on on Care Transfer (IMPACT) project Leeds teaching Hospital. Heather Smith et al 2013 Iden8fy older people at high- risk of med. related problems- started with PREVENT, used clinical judgement Medicines- related need iden8fied and medicines care plan (MCP) added to the pa8ent's discharge communica8on. Interven8ons Specific advice on medicines follow up post- discharge. Pa8ents (and or carers) educa8on Care planning, referral and sign- pos8ng to primary care and technician visit if needed Collabora8on CCG pharmacists for f/up medica8on reviews in domiciliary or care home seyngs Collabora8on with Adult Social Care: Medicines support assessments for pa8ents with re- ablement post discharge Pa8ent Needs: 86% clinical, 36% medicines support Re- admission within 30 days: 16%MCP vs 22% non- MCP
27 Community Health Services New Services and Innova+ons in Healthcare A Pragma@c approach Aim: Pharmacists take lead to iden+fy, resolve and co- ordinate medicines related care Reduce inappropriate polypharmacy and adverse effects. Improve adherence and understanding of medicines Reduce u+lisa+on of emergency services through be3er therapeu8c control of mul8ple morbidi8es Facilitate partnership working across agencies and improve medicines use during transi+ons of care Increase medicines related knowledge and skills among general prac8ce/community teams Inves8gate and develop methods of collabora+on with community pharmacy
28 New model of care: A pharmacist- led approach to op+mising medicines use for frail older in the community Pa8ent Centred, Co- ordinated, Con8nuous and Collabora8ve Frail older person during vulnerable periods & deteriora+ng health e.g. post discharge Receives GSTT Consultant/Advanced level clinical pharmacists input in the community Stable frail older person Receives generalist pharmacists ongoing input STEP 5 Community Pharmacy team implement specific long term goals within care plan. **Case management, Community MDTs, GPs, Enhanced Rapid response, Teams Liaise with GP (??Prac8ce based pharmacists) & mul8disciplinary teams Featured in the RPS Now or Never Report 2013: h3p:// of- care/models- of- care- in- ac8on.asp Winner : PresQIPP awards 2014 Shared decision making category Runner Up: Clinical Pharmacy Congress 2014: Best innova8on category 17
29 Moving towards medicines op+misa+on Pa+ent iden+fica+on Moving from drug related factors to pa8ent centred, real need vs. poten8al need Most frail elderly have high risk factors! Find the group, find the drugs! Assessment- approach and scope Moving from drug assessment to holis8c and pa8ent centred including social vulnerability, func8on as well as drugs and disease Including evidence base, then individualising drug therapy according clinical judgement and pa8ent narra8ve Interven+ons General fixed solu8ons to individualised jointly agreed solu8ons Working in silo as pharmacists in one seyng to collabora8ve and MDT/ integrated working Pharmacist to pharmacist referrals Care coordina8on- led by pharmacist as expert in use of medicines How can we make this rou+ne prac+ce?
30 FUTURE: Pharmacist- led medicines op+misa+on across secngs Social care Nurses Pharmacists in hospitals Medics Social care Carers AHP Pharmacists in community Pharmacists in primary care & community Social care providers and care homes Commissioners Research Professional bodies and regulators Educa8on
31 Learning so far. There a clear role for ALL pharmacists Need long term commissioning strategy with pharmacy workforce leading medicines op8misa8on across ALL seyngs Enable/skill up wider workforce incl. pa8ents, carers and social care Need realis8c outcomes/gains measured across the local economy Need innova8ve ways to gather research evidence research Training and clinical supervision for clinical pharmacists in community (domiciliary care/care homes) Need pharmacy champions to wn herats and minds
32 Summary Increasing numbers of frail older people Increasing pressure to deliver care closer to home for pa8ents with complex needs Polypharmacy, ADEs and support to take medicines are main issues Pa8ent experience and perspec8ve is a MUST! Many medicines related problems start at home Current clinical pharmacy exper8se and resources in community don t match need ð need a shit, closer to home In the real world.. Gathering the evidence (narra8ve) that pharmacists leading medicines op8misa8on across seyngs can reduce risks of ADE, PDRA and improve pa8ent outcomes
33 #pharmanforum Ques+ons?
Polypharmacy Reviews in the real world
S P S Community Health Services Specialist Pharmacy Service Medicines Use and Safety Polypharmacy Reviews in the real world Lelly Oboh Consultant Pharmacist, Care of Older People Guys & St Thomas NHS Founda@on
More informationMEDICINES USE AND SAFETY WEBINAR
MEDICINES USE AND SAFETY WEBINAR Welcome to the Medicines Use and Safety Team Webinar: Medicines and Frailty with Lelly Oboh The webinar itself will start at 1pm in the meantime Carina Livingstone is doing
More informationSIMPATH Y. S*mula*ng Innova*on Management of Polypharmacy and Adherence in the Elderly Simpathy
S*mula*ng Innova*on Management of Sunfrail Transla1onal workshop Understanding and caring for frailty and mul1morbidity Bologna, March 22nd 2016 S*mula*ng Innova*on Management of Polypharmacy and Adherence
More information20th June Integrated Care in Sunderland: Guide to Risk Stratification
20th June 2017 Integrated Care in Sunderland: Guide to Risk Stratification Table of Contents Integrated Care in Sunderland:... 1 Guide to Risk Stratification... 1 Table of Contents... 2 Background... 3
More informationUpper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines.
Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Chris,ne McDonough, PhD, PT, CEEAA Health Outcomes Unit Department of Health
More informationFindings from the At Home / Chez Soi Demonstration Project in Canada. Paula Goering and Catharine Hume May 2, 2013
Findings from the At Home / Chez Soi Demonstration Project in Canada Paula Goering and Catharine Hume May 2, 2013 Outline for today Overview of Project Design Na8onal level findings re one year outcomes
More informationMental Health, Substance Abuse & Primary Care: Bridging Gaps in Access
1 Mental Health, Substance Abuse & Primary Care: Bridging Gaps in Access Christopher Carroll, Director, Health Care Financing and Systems Integration Substance Abuse and Mental Health Services Administration
More informationFrailty in Geriatric Trauma Pa1ents
Division of Trauma, Burn, Surgical Critical Care, & Emergency General Surgery Frailty in Geriatric Trauma Pa1ents Zara Cooper, MD, MSc, FACS Elizabeth Bryant, MPH Disclosures NIA R01AG044518 NCI R35CA197730
More informationCommon Data Elements: Making the Mass of NIH Measures More Useful
Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series
More informationWelcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH
Pragmatic Clinical Studies David Hickam, MD, MPH Program Director Clinical Effec2veness Research June 23, 2015 Welcome! David Hickam, MD, MPH Program Director Clinical Effectiveness Research 2 In this
More informationOncology Care Model Overview
Oncology Care Model Overview Centers for Medicare & Medicaid Services Innova3on Center (CMMI) September 2017 Innova3on at CMS Center for Medicare & Medicaid Innova3on (Innova3on Center) Established by
More informationEngage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012
Engage and Empower Pa.ents with Interac.ve Technology Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 NAHAM - Pa.ent Access Services 2 Pa%ent Access Services
More informationLAI: Linee guida ed esperienze internazionali
LAI: Linee guida ed esperienze internazionali LAI: Guidelines and interna5onal experience PM Llorca CHU Clermont-Ferrand EA 7280 Université Clermont Auvergne Disclosures Advisory board: Allergan, Jansen,
More informationFRAILTY PATIENT FOCUS GROUP
FRAILTY PATIENT FOCUS GROUP Community House, Bromley 28 November 2016-10am to 12noon In attendance: 7 Patient and Healthwatch representatives: 4 CCG representatives: Dr Ruchira Paranjape went through the
More informationAddressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners
Addressing the Challenge of Medica3on Adherence Jan Berger MD, MJ President and CEO Health Intelligence Partners Drugs Have Become the Mainstay of Healthcare Treatment America s Other Drug Problem Non-adherence
More informationGOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4
GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services
More informationThe National Frailty Opportunity
Ageing Well Quality Healthcare in Later Life The National Frailty Opportunity Martin Vernon National Clinical Director Older People 1 28thSeptember 2018 Ambition for frailty.. Everybody should know what
More informationGestalt of Fatigue Risk Management within a Safety Management System
Gestalt of Fatigue Risk Management within a Safety Management System Aircraft Inspection & Maintenance Seminar Coogee Bay October 24, 2017 Robert ForsterLee Fatigue Enablers What is Gestalt? Gestalt is
More informationSCHEDULE 2 THE SERVICES. A. Service Specifications
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification 11J/0232 No. Service Enhanced Frailty Service (Christchurch MP and Farmhouse Surgery) Commissioner Lead Primary Care Team Provider
More informationPragma&c Clinical Trials
Pragma&c Clinical Trials Susanne May, PhD Associate Professor Department of Biosta&s&cs, School of Public Health, University of Washington Preliminaries PLEASE ask ques&ons at any &me REALLY good clinical
More informationAgeing Well. The challenge of our ageing population. Martin Vernon NCD Older People. Find Recognise Assess Intervene Long-term.
Ageing Well The challenge of our ageing population Martin Vernon NCD Older People 7 th June 2017 1 Projected UK age structure Foresight, 2016 2 Ageing impacts 15 million live with a long term condition
More informationDevelopment and Applica0on of Real- Time Clinical Predic0ve Models
Development and Applica0on of Real- Time Clinical Predic0ve Models Ruben Amarasingham, MD, MBA Associate Professor, UT Southwestern Medical Center AHRQ- funded R24 UT Southwestern Center for Pa?ent- Centered
More informationEffec&ve Messaging for Suicide Preven&on:
Effec&ve Messaging for Suicide Preven&on: Anara Guard anara@suicideispreventable.org Lessons from a statewide campaign and from a na&onal framework This morning The Know the Signs statewide social marke&ng
More informationAssisted Living s Whole Brain Fitness: Can It Prevent Re-hospitalization?
Assisted Living s Whole Brain Fitness: Can It Prevent Re-hospitalization? Health Care Environment Is Changing, Opening Up New Opportuni:es for Assisted Living Center for Medicaid & Medicare Services (CMS)
More informationNational Frailty Approach
Ageing Well Quality Healthcare in Later Life National Frailty Approach Martin Vernon National Clinical Director Older People 1 Crawley www.england.nhs.uk 10 th May 2018 Ambition for frailty.. Everybody
More information1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy
1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy (ART) for women living with HIV 2. This is the first
More informationFalls in older patients with cancer: Impact on treatment, fall assessment and reporting
Falls in older patients with cancer: Impact on treatment, fall assessment and reporting Schroder Sa*ar 1, Shabbir Alibhai 2, Sandra Spoelstra 3, Mar8ne MTE Puts 1 1 Lawrence S. Bloomberg Faculty of Nursing,
More informationMedication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015
Medication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015 Objectives An ini%al target market survey was launched in May 2011 to serve as a benchmark
More informationChanging care systems for people with frailty. John Young
Changing care systems for people with frailty John Young Geriatrician, Bradford Hospitals Trust, UK National Clinical Director for Integration & the Frail Elderly, NHS England (john.young@bthft.nhs.uk)
More informationMedicines Optimisation the opportunities and challenges. Christina Short Medicines Optimisation Project Manager
Medicines Optimisation the opportunities and challenges Christina Short Medicines Optimisation Project Manager The remit:- Clinical Pharmacy input into the Locality Model Proposal: To contract a senior
More informationafter acute care (inc. ED)?
How to prevent early & unplanned hospital admission after acute care (inc. ED)? Luis Mieiro @luismieiro Consultant Geriatrician Forest Assessment Unit - Older People s Services Whipps Cross University
More informationDiabetes Self- management Educa4on and Support (DSME/S)
Improving Patient Care Through Diabetes Self- management Education Davida F. Kruger, MSN, APN-BC, BC-ADM Certified Nurse Practitioner Henry Ford Health System Division of Endocrinology, Diabetes, Bone
More informationSuppor&ng the Mental Health of Looked- A7er Children Across the Primary- Secondary Transi&on
Suppor&ng the Mental Health of Looked- A7er Children Across the Primary- Secondary Transi&on Helen Drew, & Robin Banerjee (University of Sussex), Mary John (University of Surrey) and Nikki Luke & Judy
More informationPublished: 10/06/2014. Heart Failure Pathways
Heart Failure Pathways Diagnosing Heart Failure Page 1 of 2 Pa$ent presents with symptoms possibly due to heart failure, dyspnoea, fa$gue, exercise, intolerance, oedema History : Onset of symptoms (dura$on)
More informationBeen there, done it, got the T- shirt: Life in Med Comms. Stephen Paterson Freelance Med Comms Specialist
Been there, done it, got the T- shirt: Life in Med Comms Stephen Paterson Freelance Med Comms Specialist Ques?ons, ques?ons... Who am I? Why am I talking to you today? What am I going to talk about? Why
More informationInfluencing planning to improve the quality of Parkinson s care in Scotland
Influencing planning to improve the quality of Parkinson s care in Scotland This short guide enables you to influence commissioning by making the case for high quality, cost-effective care for people affected
More informationEconomic outcomes: Method for implementa5on
Economic outcomes: Method for implementa5on Philippe Beutels Centre for Health Economics Research & Modelling Infec
More informationClinical Research Project Design and Guidelines: Choosing a Research Ques8on
Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Odunayo M. Oluwatosin, FMCS (Nig) Department of Plas?c Surgery University College Hospital Ibadan 1 Learning outcome: by the
More informationCommunity alcohol detoxification in primary care
Community alcohol detoxification in primary care 1. Purpose The purpose of this primary care enhanced service is to improve the health and quality of life of people whose health may be compromised by their
More informationSpo$ng and Managing Delayed Recovery in Injured Workers
Disclosure Informa5on Western Occupa5onal Health Conference 2011 I have the following financial rela5onships to disclose: I have nothing to disclose - and- I will not discuss off label use and/or inves5ga5onal
More informationPresentation of a specific research project
Presentation of a specific research project Appropriate use of medicines in care of the elderly: Factors underlying inappropriateness, and impact of the clinical pharmacist Anne Spinewine 04.10.2011 WBI-
More informationTo have loved and lost: A group for students who have lost a loved one
To have loved and lost: A group for students who have lost a loved one 1 Background Informa;on A bereaved person is grieving the loss of someone (or something) he or she valued Loss can nega;vely impact
More informationA New Innova+ve Approach to Integrate Pa+ent Preferences into the Sta+s+cal Design for Clinical Trials: A Collabora+ve Case Study
A New Innova+ve Approach to Integrate Pa+ent Preferences into the Sta+s+cal Design for Clinical Trials: A Collabora+ve Case Study A Collabora)on of the Medical Device Innova)on Consor)um, FDA, MIT, RTI
More informationEthics and Boundaries
Ethics and Boundaries Jim Seckman, MAC, CACII, CCS What are the defining characteris@cs of a profession? A body of knowledge A special group of skills Addresses a special problem Tes@ng for admission Lifelong
More informationFrailty Pathway A patient centred approach Guidance for Clinicians
Frailty Pathway A patient centred approach Guidance for Clinicians Prompt Cards June 2015 following a CCG sponsored County wide frailty Summit the Edmonton Frailty Scale was agreed as the tool to, identify
More informationBuilding Capacity to Support Children With Hearing Loss in Vietnam
Building Capacity to Support Children With Hearing Loss in Vietnam Paige Stringer, M.A. Founder and Executive Director Global Foundation For Children With Hearing Loss May 3, 2013 Sta>s>cs: World Bank
More informationLearning Objec1ves. Study Design Considera1ons in Clinical Pharmacy
9/28/15 Study Design Considera1ons in Clinical Pharmacy Ludmila Bakhireva, MD, PhD, MPH Pree Sarangarm, PharmD, BCPS Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal
More informationEvidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on. Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs
Evidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs Maureen Dailey, PhD, RN, CWOCN CMS Leadership to Reduce
More informationThe design of the PRaCTICED trial: Decisions, decisions, decisions
The design of the PRaCTICED trial: Decisions, decisions, decisions Michael Barkham Centre for Psychological Services Research University of Sheffield Metanoia: September 2013 Acknowledgements BACP Research
More informationLearning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15
9/28/15 Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal study designs Explain why the overall study design is important when evalua1ng studies & applying their
More informationCare at the End. Transi.oning to a pallia.ve approach for frail elders at home
Care at the End Transi.oning to a pallia.ve approach for frail elders at home November 12, 2015 Dr. Jay Slater Vancouver, BC jay.slater@vch.ca Disclosures No real or perceived conflicts of interest No
More informationMental Health in STH Mike Richmond, Medical Director Mark Cobb, Clinical Director of Professional Services Debate & Note
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE TRUST HEALTHCARE GOVERNANCE COMMITTEE E TO BE HELD ON 27 FEBRUARY 2012 Subject: Supporting Director: Author: Status 1 Mental
More informationThe future of ARIA guidelines
The future of ARIA guidelines Evidence- based medicine GRADE Recommenda
More informationDepartment of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017
Department of Emergency Medicine Office of Research Shannon McNabb, MA, MPH Clinical Research Manager January 2017 EM Study Tracking System UPDATED ON: 12/5/2016 TOTAL 68 Grants Submitted, Award Pending
More informationPosi%ve Psychotherapy for Youth at Clinical High- Risk for Psychosis
Posi%ve Psychotherapy for Youth at Clinical High- Risk for Psychosis Lauren Drvaric, MSc. Psych., PhD. Candidate (co- inves%gator) Doctoral Research Trainee, Complex Mental Illness, Centre for Addic%on
More informationPsychological outcomes of cri2cal illness for pa2ents and family members. Erin K. Kross, MD Summer Lung Day June 18, 2010
Psychological outcomes of cri2cal illness for pa2ents and family members Erin K. Kross, MD Summer Lung Day June 18, 2010 Outline Overview of psychological outcomes for pa2ents and family members ager cri2cal
More informationIntegration; Frailty; and efi
Integration; Frailty; and efi John Young Geriatrician, Bradford Hospitals Trust, UK National Clinical Director for Integration & the Frail Elderly, NHS England (john.young@bthft.nhs.uk) NHS England Older
More informationResolving the PSA testing controversy. Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg
Resolving the PSA testing controversy Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg Professor Villis Marshall AC Introduc)on Guidelines aim to inform tes)ng for the
More informationMedica8on Assisted Treatment (MAT) in Jails and Community- Based SeDngs
Medica8on Assisted Treatment (MAT) in Jails and Community- Based SeDngs Lisa Ramirez, Lead Program Specialist, Texas Department of State Health Services, Mental Health and Substance Abuse Division Rebecca
More informationMCIP Recruitment Pack
MCIP Recruitment Pack Page 1 of 13 Welcome Thank you for the interest you have shown in the MCIP Programme. An exciting partnership has been established to redesign cancer care in Manchester. Funded by
More informationBrief Ac)on Planning A White Paper
Brief Ac)on Planning A White Paper Authors: Kathy Reims, MD Damara Gutnick, MD Connie Davis, MN, ARNP Steven Cole, MD January 2013 updated September 2014 Centre for Collabora)on, Mo)va)on and Innova)on
More informationSuicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force
Suicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force David A. Jobes, Ph.D., ABPP Professor of Psychology Associate Director of Clinical Training The Catholic
More informationUNCONSCIOUS BIAS What is it? Sponsored by InDemand Interpre1ng
1 UNCONSCIOUS BIAS What is it? 2 Unconscious Bias: What is it? How does it work? By: David B. Hunt, J.D. President and CEO, Cri8cal Measures Awareness: New Research Regarding Bias 3 In the past, bias was
More informationSandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services?
Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services? Dr PARIJAT DE DUK Clinical Champion Clinical Lead for Diabetes & Endocrinology, Sandwell & West
More informationTHE WIRE (Women s Informa2on and Rese4lement for Ex- offenders) EVALUATION REPORT November A burden shared is a burden halved
THE WIRE (Women s Informa2on and Rese4lement for Ex- offenders) EVALUATION REPORT November 2012 A burden shared is a burden halved 1 Contents page Page 2tle Page number How to use this document 3 Glossary
More informationEMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY
EMU A NEW MODEL OF EMERGENCY CARE FOR THE FRAIL & ELDERLY Geriatrics, General practice, Emergency medicine, Interface medicine SUMMARY An integrated, community emergency service specifically designed for
More informationClinical Staging and the At-Risk Phase of Psychotic Disorder
Clinical Staging and the At-Risk Phase of Psychotic Disorder Sabina Abidi MD FRCPC IWK Youth Psychosis Program Capital Health Nova ScoCa Early Psychosis Program Key Findings in Early Psychosis Knowledge
More informationPopulation Health Analytics and Usage of the ACG System in the UK Stockholm, 13 th June, 2017 Alan Thompson, Director of User Support
Population Health Analytics and Usage of the ACG System in the UK Stockholm, 13 th June, 2017 Alan Thompson, Director of User Support athompson@hopkinsacg.org Content Summary of main uses of the ACG System
More informationEthics and Boundaries
Ethics and Boundaries Jim Seckman, MAC, CACII, CCS What are the defining characteris@cs of a profession? A body of knowledge A special group of skills Addresses a special problem Tes@ng for admission Lifelong
More informationAppendix 1. Cognitive Impairment and Dementia Service Elm Lodge 4a Marley Close Greenford Middlesex UB6 9UG
Appendix 1 Mr Dwight McKenzie Scrutiny Review Officer Legal and Democratic Services Ealing Council Perceval House 14 16 Uxbridge Road Ealing London W5 2HL Cognitive Impairment and Dementia Service Elm
More informationAssessment of the Elderly Pa2ent. Irwin Foo Western General Hospital Edinburgh
Assessment of the Elderly Pa2ent Irwin Foo Western General Hospital Edinburgh UK Demographics Fastest increase in the oldest old 2009-1.4 million age > 85 years 2034 -?3.5 million Life Expectancy Males
More informationDo shared care wards work?
Do shared care wards work? Prof Rowan H. Harwood Nottingham University Hospitals NHS Trust & University of Nottingham rowan.harwood@nuh.nhs.uk This presentation is on independent research funded by the
More informationAcute care for older people with frailty
Acute care for older people with frailty Professor Simon Conroy Clinical lead, Acute Frailty Network, England Geriatrician, University Hospitals of Leicester Why acute frailty? Demography Absence of immortality
More informationTest and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire
Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Introduction This document introduces South Gloucestershire Clinical Commissioning
More informationAgeing Well. Avoiding falls in older people. Prof Martin Vernon NCD Older People. Find Recognise Assess Intervene Long-term.
Ageing Well Avoiding falls in older people Prof Martin Vernon NCD Older People 21 October 2016 1 Its not how old we are, but how we are old 2 Key points 1. Demography 2. Frailty & falls 3. Routine frailty
More informationJosep M Borras WP7 Health Care University of Barcelona and Spanish Cancer Strategy Brussels, June 23, 2014
THE IMPORTANCE OF SHARING EXPERTISE AND THE CHALLENGE TO MANAGE THE EXCHANGE OF KNOWLEDGE IN HIGHLY SPECIALISED HEALTH CARE: a perspec(ve from the European Partnership Ac(on Against Cancer (EPAAC) Josep
More informationOffice of Training and Capacity Development AIDS Educa<on and Training Centers Overview
Office of Training and Capacity Development AIDS Educa
More informationGlobal Treatment Access Review Par$cipatory Methodology. Dr. Alice Welbourn Salamander Trust Founding Director
Global Treatment Access Review Par$cipatory Methodology Dr. Alice Welbourn Salamander Trust Founding Director Presenta5on overview What research exists? Research ques$ons Theore$cal Framework Key review
More informationHospital at Home. Frailty and Hospital at Home. 17 th March Pam Livingstone and Gwyneth Thom
Hospital at Home Frailty and Hospital at Home 17 th March 2016 Pam Livingstone and Gwyneth Thom National Definition of Hospital at Home December 2013 An episode of specialist care delivered at home as
More informationBlue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results
Blue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results Margaret Mason, MHSA Michael Paus6an, PhD, MS Amanda Markovitz, MPH 1 Overview of BCBSM Serving
More informationNeurocogni*ve tes*ng and cochlear implanta*on: insights into performance in older adults
Neurocogni*ve tes*ng and cochlear implanta*on: insights into performance in older adults Maura K Cosetti 1 MD James B. Pinkston, PhD 1 ; Jose M. Flores, MPH, PhD 3 ; David R. Friedmann, MD 2 ; Callie B.
More informationSCHEDULE 2 THE SERVICES. A. Service Specifications
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. 04/MSKT/0013 Service PAN DORSET FRACTURE LIAISON SERVICE Commissioner Lead CCP for Musculoskeletal & Trauma Provider Lead Deputy
More informationE. Scafato C. Gandin, L. Galluzzo, S. Ghirini, S. Martire, R. Scipione Istituto Superiore di Sanità, Italy
Guidelines to support early identification and brief interventions for alcohol use disorders in Europe: overview of RARHA survey results and of other EU projects E. Scafato C. Gandin, L. Galluzzo, S. Ghirini,
More informationNHS RightCare Frailty Pathway An optimal frailty system
NHS RightCare Frailty Pathway An optimal frailty system Martin Vernon National Clinical Director for Older People Adrian Hopper Consultant Physician & Frailty Pathway GiRFT Lead Alex Thompson Pathways
More informationDRAFTv9 Appendix 1 SCHEDULE 2 THE SERVICES. A. Service Specifications (Short Form Contract)
DRAFTv9 Appendix 1 SCHEDULE 2 THE SERVICES A. Service Specifications (Short Form Contract) Service Specification TO BE COMPLETED BY CONTRACTING No. Service Enhanced Frailty Service Commissioner Lead Dorset
More informationASSET- BASED COMMUNITY DEVELOPMENT & SBCB: THEORY
Short Guide to ABCD - The art of asking the right questions ASSET- BASED COMMUNITY DEVELOPMENT & SBCB: THEORY DEFICIT- BASED ASSET- BASED Problems Possibili9es Blame Shared ownership What s missing What
More informationPeople living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals
PROJECT INITIATION DOCUMENT We re in it together People living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals Version: 1.1 Date: February 2011 Authors: Jillian
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationIdentifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems
Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Jose Pepe L. Contreras-Vidal, Ph.D. Department of Electrical & Computer
More informationChronic Kidney Disease
Chronic Kidney Disease Management Issues in the Hospital and Beyond in pre dialysis CKD pa;ents Brian Wolfe, MD Assistant Professor of Medicine University of Colorado Denver, Hospital Medicine Sec;on Case:
More information#nhstestbeds. NHS Test Beds: Testing innovations in real world settings
#nhstestbeds NHS Test Beds: Testing innovations in real world settings #nhstestbeds Test Beds Wave 1 51 digital products 4000+ patients recruited Test Beds Wave 1 75 partnership organizations 40 innovators
More informationChemo Brain and Fa.gue Chemotherapy Related Cogni:ve Impairment Chemotherapy Related Fa:gue. Alok Pant, MD Northwestern Medicine
Chemo Brain and Fa.gue Chemotherapy Related Cogni:ve Impairment Chemotherapy Related Fa:gue Alok Pant, MD Northwestern Medicine Chemotherapy Related Cogni.ve Changes Agen:on Concentra:on Learning Memory
More informationDELIVERING OUR STRATEGY: FOR YOU, WITH YOU
#wearenhft Northamptonshire Healthcare NHS Foundation Trust DELIVERING OUR STRATEGY: FOR YOU, WITH YOU OUR STRATEGIC PLAN: 2018-2023 01604 682682 01604 682682 nhft.nhs.uk FOR YOU, WITH YOU ABOUT NHFT We
More informationStacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD. Stacie Fruth, PT, DHSc, OCS
Physical Therapists on the Emergency Department Team: PT and MD Perspec8ves Stacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD Combined Sec,ons
More informationConnecting 4 You Frailty Strategy High Weald Lewes Havens CCG. January Version 1.11 (170118)
Connecting 4 You Frailty Strategy 2017 2020 High Weald Lewes Havens CCG January 2018 Version 1.11 (170118) Page 2 of 18 Contents Executive Summary.. 3 Why is Frailty a priority?. 3 Size and impact of problem...
More informationReshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality
Reshaping Care Pathways for Older People Anne Hendry National Clinical Lead for Quality Reshaping Care for Older People 10 Year Programme to 2021 300 million Change Fund to 2015 32 Partnerships between
More informationWhat is Frailty? National Background and Local Pathways
What is Frailty? National Background and Local Pathways Learning Outcomes At the end of the session you will be able to :Know where to go to look at key national resources on frailty. Define frailty. Screen
More informationA review of approaches to identifying patient phenotype cohorts using electronic health records
A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March
More informationNutri'on Promo'on: Industries contribu'ons and key considera'ons
Nutri'on Promo'on: Industries contribu'ons and key considera'ons Presented by: FEDERATION OF MALAYSIAN MANUFACTURERS MALAYSIAN FOOD MANUFACTURING GROUP (FMM MAFMAG) Outline Our commitments Contribu'ons
More informationPerspec'vas Psicologicas en el Cuidado de la Diabetes
Perspec'vas Psicologicas en el Cuidado de la Diabetes Antonio E. Puente University of North Carolina Wilmington Universidad de la Ciudad de Juarez 09.20.13 Health Sta's'cs: 2010 (The Economist, 12.12.09)
More information